Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)
- 6 February 2006
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 24 (6), 703-707
- https://doi.org/10.1016/j.vaccine.2005.07.069
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Symposium on the Definition and Management of Anaphylaxis: Summary reportJournal of Allergy and Clinical Immunology, 2005
- Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS)Vaccine, 2004
- Safety of immunisation and adverse events following vaccination against hepatitis BExpert Opinion on Drug Safety, 2003
- The gelatin storyJournal of Allergy and Clinical Immunology, 1999
- Baker’s asthma: Still among the most frequent occupational respiratory disordersJournal of Allergy and Clinical Immunology, 1998
- Baker’s asthma caused by Saccharomyces cerevisiaein dry powder formJournal of Allergy and Clinical Immunology, 1996
- The vaccine adverse event reporting system (VAERS)Vaccine, 1994
- Clinical experience with hepatitis B vaccinesAmerican Journal of Infection Control, 1989
- YEAST-DERIVED HEPATITIS B VACCINE AND YEAST SENSITIVITYThe Lancet, 1989
- Lack of Induction of IgE and IgG Antibodies to Yeast in Humans Immunized with Recombinant Hepatitis B VaccinesInternational Archives of Allergy and Immunology, 1988